 | • レポートコード：TPM-C03006 • 出版社/出版日：Transparency Market Research / 2019年2月19日 • レポート形態：英文、PDF、220ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、眼科手術用装置および治療薬（アイケア）の世界市場について調べ、眼科手術用装置および治療薬（アイケア）の世界規模、市場動向、市場環境、製品タイプ別（治療薬、手術器具、ビジョンケア）分析、エンドユーザー別（病院、眼科クリニック、通院外科診療所）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・眼科手術用装置および治療薬（アイケア）の世界市場動向 ・眼科手術用装置および治療薬（アイケア）の世界市場環境 ・眼科手術用装置および治療薬（アイケア）の世界市場規模 ・眼科手術用装置および治療薬（アイケア）の世界市場規模：製品タイプ別（治療薬、手術器具、ビジョンケア） ・眼科手術用装置および治療薬（アイケア）の世界市場規模：エンドユーザー別（病院、眼科クリニック、通院外科診療所） ・眼科手術用装置および治療薬（アイケア）の世界市場：地域別市場規模・分析 ・眼科手術用装置および治療薬（アイケア）の北米市場規模・予測 ・眼科手術用装置および治療薬（アイケア）のアメリカ市場規模・予測 ・眼科手術用装置および治療薬（アイケア）の中南米市場規模・予測 ・眼科手術用装置および治療薬（アイケア）のヨーロッパ市場規模・予測 ・眼科手術用装置および治療薬（アイケア）のアジア市場規模・予測 ・眼科手術用装置および治療薬（アイケア）の日本市場規模・予測 ・眼科手術用装置および治療薬（アイケア）の中国市場規模・予測 ・眼科手術用装置および治療薬（アイケア）のインド市場規模・予測 ・眼科手術用装置および治療薬（アイケア）の中東市場規模・予測 ・眼科手術用装置および治療薬（アイケア）のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Ophthalmic Surgical Devices and Therapeutics Market: Overview
This report analyzes the current and future scenario of the global ophthalmic surgical devices and therapeutics market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of ocular disorders, and high unmet medical needs are likely to be major drivers of the global ophthalmic surgical devices and therapeutics market during the forecast period.
The ophthalmic surgical devices and therapeutics market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on product type, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the ophthalmic surgical devices and therapeutics market.
Ophthalmic Surgical Devices and Therapeutics Market: Key Segments
Based on product type, the global ophthalmic surgical devices and therapeutics market has been segmented into therapeutics, surgical devices, and vision care. In terms of end-user, the global ophthalmic surgical devices and therapeutics market has been divided into hospitals, ophthalmic clinics, and ambulatory surgery centers. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.
Ophthalmic Surgical Devices and Therapeutics Market: Regional Outlook
In terms of region, the global ophthalmic surgical devices and therapeutics market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in the Report
The report also profiles major players operating in the global ophthalmic surgical devices and therapeutics market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Carl Zeiss Meditec AG, HOYA Corporation, and Bayer AG. The global ophthalmic surgical devices and therapeutics market has been segmented as below:
Ophthalmic Surgical Devices and Therapeutics Market, by Product Type
Therapeutics
Anti-inflammatory Drugs
NSAIDs
Steroids
Anti-infective Drugs
Anti-fungal Drugs
Anti-bacterial Drugs
Others
Anti-infective Drugs
Alpha Agonist
Beta Blockers
Prostaglandin Analogs
Combined Medication
Others
Anti-allergy Drugs
Anti-VEGF Agents
Others
Surgical Devices
Cataract Surgery Devices
Intraocular lens (IOL)
Ophthalmic Viscoelastic Devices (OVDs)
Others
Glaucoma Surgery Devices
Refractive Surgery Devices
Vitreoretinal Surgery Devices
Vision Care
Contact Lenses
Spectacle Lenses
Accessories
Ophthalmic Surgical Devices and Therapeutics Market, by End-user
Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers
Ophthalmic Surgical Devices and Therapeutics Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Ophthalmic Surgical Devices and Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Pipeline Analysis
5.2. Technological Advancements
5.3. Snapshot: Ocular Diseases Leading to Visual Impairment & Analysis of Global Causes of Blindness (%)
6. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
6.3.1. Therapeutics
6.3.1.1. Anti-inflammatory Drugs
6.3.1.1.1. NSAIDs
6.3.1.1.2. Steroids
6.3.1.2. Anti-infective Drugs
6.3.1.2.1. Anti-fungal Drugs
6.3.1.2.2. Anti-bacterial Drugs
6.3.1.2.3. Others
6.3.1.3. Anti-glaucoma Drugs
6.3.1.3.1. Alpha Agonist
6.3.1.3.2. Beta Blockers
6.3.1.3.3. Prostaglandin Analogs
6.3.1.3.4. Combined Medication
6.3.1.3.5. Others
6.3.1.4. Anti-allergy Drugs
6.3.1.5. Anti-VEGF Agents
6.3.1.6. Others
6.3.2. Surgical Devices
6.3.2.1. Cataract Surgery Devices
6.3.2.1.1. Intraocular lens (IOL)
6.3.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
6.3.2.1.3. Others
6.3.2.2. Glaucoma Surgery Devices
6.3.2.3. Refractive Surgery Devices
6.3.2.4. Vitreoretinal Surgery Devices
6.3.3. Vision Care
6.3.3.1. Contact Lenses
6.3.3.2. Spectacle Lenses
6.3.3.3. Accessories
6.4. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type
7. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
7.3.1. Hospitals
7.3.2. Ophthalmic Clinics
7.3.3. Ambulatory Surgery Centers
7.4. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user
8. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Region
9. North America Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
9.2.1. Therapeutics
9.2.1.1. Anti-inflammatory Drugs
9.2.1.1.1. NSAIDs
9.2.1.1.2. Steroids
9.2.1.2. Anti-infective Drugs
9.2.1.2.1. Anti-fungal Drugs
9.2.1.2.2. Anti-bacterial Drugs
9.2.1.2.3. Others
9.2.1.3. Anti-glaucoma Drugs
9.2.1.3.1. Alpha Agonist
9.2.1.3.2. Beta Blockers
9.2.1.3.3. Prostaglandin Analogs
9.2.1.3.4. Combined Medication
9.2.1.3.5. Others
9.2.1.4. Anti-allergy Drugs
9.2.1.5. Anti-VEGF Agents
9.2.1.6. Others
9.2.2. Surgical Devices
9.2.2.1. Cataract Surgery Devices
9.2.2.1.1. Intraocular lens (IOL)
9.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
9.2.2.1.3. Others
9.2.2.2. Glaucoma Surgery Devices
9.2.2.3. Refractive Surgery Devices
9.2.2.4. Vitreoretinal Surgery Devices
9.2.3. Vision Care
9.2.3.1. Contact Lenses
9.2.3.2. Spectacle Lenses
9.2.3.3. Accessories
9.3. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals
9.3.2. Ophthalmic Clinics
9.3.3. Ambulatory Surgery Centers
9.4. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country, 2016–2026
9.4.1. US
9.4.2. Canada
9.5. North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
10.2.1. Therapeutics
10.2.1.1. Anti-inflammatory Drugs
10.2.1.1.1. NSAIDs
10.2.1.1.2. Steroids
10.2.1.2. Anti-infective Drugs
10.2.1.2.1. Anti-fungal Drugs
10.2.1.2.2. Anti-bacterial Drugs
10.2.1.2.3. Others
10.2.1.3. Anti-glaucoma Drugs
10.2.1.3.1. Alpha Agonist
10.2.1.3.2. Beta Blockers
10.2.1.3.3. Prostaglandin Analogs
10.2.1.3.4. Combined Medication
10.2.1.3.5. Others
10.2.1.4. Anti-allergy Drugs
10.2.1.5. Anti-VEGF Agents
10.2.1.6. Others
10.2.2. Surgical Devices
10.2.2.1. Cataract Surgery Devices
10.2.2.1.1. Intraocular lens (IOL)
10.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
10.2.2.1.3. Others
10.2.2.2. Glaucoma Surgery Devices
10.2.2.3. Refractive Surgery Devices
10.2.2.4. Vitreoretinal Surgery Devices
10.2.3. Vision Care
10.2.3.1. Contact Lenses
10.2.3.2. Spectacle Lenses
10.2.3.3. Accessories
10.3. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
10.3.1. Hospitals
10.3.2. Ophthalmic Clinics
10.3.3. Ambulatory Surgery Centers
10.4. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. France
10.4.3. U.K.
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
11.2.1. Therapeutics
11.2.1.1. Anti-inflammatory Drugs
11.2.1.1.1. NSAIDs
11.2.1.1.2. Steroids
11.2.1.2. Anti-infective Drugs
11.2.1.2.1. Anti-fungal Drugs
11.2.1.2.2. Anti-bacterial Drugs
11.2.1.2.3. Others
11.2.1.3. Anti-glaucoma Drugs
11.2.1.3.1. Alpha Agonist
11.2.1.3.2. Beta Blockers
11.2.1.3.3. Prostaglandin Analogs
11.2.1.3.4. Combined Medication
11.2.1.3.5. Others
11.2.1.4. Anti-allergy Drugs
11.2.1.5. Anti-VEGF Agents
11.2.1.6. Others
11.2.2. Surgical Devices
11.2.2.1. Cataract Surgery Devices
11.2.2.1.1. Intraocular lens (IOL)
11.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
11.2.2.1.3. Others
11.2.2.2. Glaucoma Surgery Devices
11.2.2.3. Refractive Surgery Devices
11.2.2.4. Vitreoretinal Surgery Devices
11.2.3. Vision Care
11.2.3.1. Contact Lenses
11.2.3.2. Spectacle Lenses
11.2.3.3. Accessories
11.3. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
11.3.1. Hospitals
11.3.2. Ophthalmic Clinics
11.3.3. Ambulatory Surgery Centers
11.4. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
12.2.1. Therapeutics
12.2.1.1. Anti-inflammatory Drugs
12.2.1.1.1. NSAIDs
12.2.1.1.2. Steroids
12.2.1.2. Anti-infective Drugs
12.2.1.2.1. Anti-fungal Drugs
12.2.1.2.2. Anti-bacterial Drugs
12.2.1.2.3. Others
12.2.1.3. Anti-glaucoma Drugs
12.2.1.3.1. Alpha Agonist
12.2.1.3.2. Beta Blockers
12.2.1.3.3. Prostaglandin Analogs
12.2.1.3.4. Combined Medication
12.2.1.3.5. Others
12.2.1.4. Anti-allergy Drugs
12.2.1.5. Anti-VEGF Agents
12.2.1.6. Others
12.2.2. Surgical Devices
12.2.2.1. Cataract Surgery Devices
12.2.2.1.1. Intraocular lens (IOL)
12.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
12.2.2.1.3. Others
12.2.2.2. Glaucoma Surgery Devices
12.2.2.3. Refractive Surgery Devices
12.2.2.4. Vitreoretinal Surgery Devices
12.2.3. Vision Care
12.2.3.1. Contact Lenses
12.2.3.2. Spectacle Lenses
12.2.3.3. Accessories
12.3. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
12.3.1. Hospitals
12.3.2. Ophthalmic Clinics
12.3.3. Ambulatory Surgery Centers
12.4. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
13.2.1. Therapeutics
13.2.1.1. Anti-inflammatory Drugs
13.2.1.1.1. NSAIDs
13.2.1.1.2. Steroids
13.2.1.2. Anti-infective Drugs
13.2.1.2.1. Anti-fungal Drugs
13.2.1.2.2. Anti-bacterial Drugs
13.2.1.2.3. Others
13.2.1.3. Anti-glaucoma Drugs
13.2.1.3.1. Alpha Agonist
13.2.1.3.2. Beta Blockers
13.2.1.3.3. Prostaglandin Analogs
13.2.1.3.4. Combined Medication
13.2.1.3.5. Others
13.2.1.4. Anti-allergy Drugs
13.2.1.5. Anti-VEGF Agents
13.2.1.6. Others
13.2.2. Surgical Devices
13.2.2.1. Cataract Surgery Devices
13.2.2.1.1. Intraocular lens (IOL)
13.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
13.2.2.1.3. Others
13.2.2.2. Glaucoma Surgery Devices
13.2.2.3. Refractive Surgery Devices
13.2.2.4. Vitreoretinal Surgery Devices
13.2.3. Vision Care
13.2.3.1. Contact Lenses
13.2.3.2. Spectacle Lenses
13.2.3.3. Accessories
13.3. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
13.3.1. Hospitals
13.3.2. Ophthalmic Clinics
13.3.3. Ambulatory Surgery Centers
13.4. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles
14.2.1. Allergan plc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.2. Novartis AG
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.3. Johnson & Johnson Vision Care, Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.4. Bayer AG
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.5. F. Hoffmann-La Roche Ltd.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.6. Bausch Health Companies Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.7. Regeneron Pharmaceuticals, Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.8. Santen Pharmaceutical Co., Ltd.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.9. HOYA Corporation
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.5.10. Carl Zeiss Meditec AG
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
Table 01: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 02: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 03: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016–2026
Table 04: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016–2026
Table 05: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, Anti-glaucoma Drugs, 2016–2026
Table 06: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 07: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 08: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 09: Global Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 10: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 11: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 12: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 13: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 14: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-inflammatory Drugs, 2016–2026
Table 15: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-infective Drugs, 2016–2026
Table 16: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics- Anti-glaucoma Drugs, 2016–2026
Table 17: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 18: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 19: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 20: North America Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 22: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 23: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 24: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-inflammatory Drugs, 2016–2026
Table 25: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-infective Drugs, 2016–2026
Table 26: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics- Anti-glaucoma Drugs, 2016–2026
Table 27: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 28: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 29: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 30: Europe Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 31: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 32: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 33: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 34: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016–2026
Table 35: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016–2026
Table 36: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016–2026
Table 37: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 38: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 39: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 40: Asia Pacific Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 41: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 42: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 43: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 44: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016–2026
Table 45: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016–2026
Table 46: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016–2026
Table 47: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 48: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 49: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 50: Latin America Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 51: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 52: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 53: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 54: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016–2026
Table 55: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016–2026
Table 56: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016–2026
Table 57: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 58: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 59: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 60: Middle East & Africa Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026